NTVH - 2018, nummer 8, november 2018
dr. W. Zeijlemaker
Op 22 november 2017 promoveerde Wendelien Zeijlemaker aan de Vrije Universiteit van Amsterdam op haar promotieonderzoek getiteld ‘Leukemic stem cells and measurable residual disease in AML: an emerging new outcome parameter’, onder begeleiding van promotor prof. dr. G.J. Ossenkoppele en copromotor dr. G.J. Schuurhuis. In deze bespreking worden de belangrijkste bevindingen van het onderzoek weergegeven.
(NED TIJDSCHR HEMATOL 2018;15:416–20)
Lees verderTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
